Could a simple paper strip revolutionize mpox testing?

NCT ID NCT07634081

Recruiting now Diagnosis Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new way to collect and transport samples for mpox diagnosis using a special paper strip treated with SDS and EDTA. The strip inactivates the virus, making transport safer, and stabilizes the genetic material so cold storage isn't needed. Researchers will compare this method to the usual swab method in 150 patients in the Democratic Republic of the Congo to see if it works just as well.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SDS-EDTA-treated chromatography strip
What this could lead to: If successful, this could provide a simpler, safer way to collect and transport mpox samples without needing cold storage, making diagnosis easier in remote areas.
What could go wrong: This is a small, early-stage study (150 participants) comparing a new method to standard swabs. The new method may not be as accurate or practical in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MPOX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

monkeypox

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MPOX

Contacts and locations

Locations

Miti-Murhesa General Referral Hospital and affiliated healthcare facilities in South Kivu
RECRUITING

Bukavu, Democratic Republic of the Congo

More trials for these conditions

Other studies related to the condition(s) this trial covers.